-
A 52-year-old woman had systemic symptoms including nausea and vomiting. Seven months prior to admission she had a subarachnoid hemorrhage and needed multiple ventriculo-pleural shunts.
-
Raltegravir (RAL) received FDA approval in 2007 and is now used in treatment of both treatment-experienced and treatment-naïve patients.
-
A previously healthy 51-year-old man with no history of travel outside of Montana presented to a local emergency department in May 2009 with fever, frontal headache, dizziness, numbness, and tingling.
-
A randomized, double-blind, placebo-controlled trial of immediate vs. deferred ART in 253 patients with HIV-associated TB meningitis was conducted to determine whether immediate ART reduced the risk of death.
-
The numbers of households with pets are increasing in many countries across the world. In addition, data obtained from media sources note a trend in the percentage of these pets sleeping in, or on, the owner's bed.
-
A wide variety of resources have been developed over the last several years, primarily Internet-based, to assist the critical care provider in managing patients in the ICU.
-
The purpose of this prospective, observational study was to report on the feasibility and safety of limiting sedation throughout a patient's ICU stay.
-
In this issue: Two new drugs for treatment of hepatitis C; NSAIDs and myocardial infarction risk; AIM-HIGH clinical trial stopped; and FDA actions.
-
Current guidelines for the use of emergency oxygen recommend its judicious use in patients with obesity-associated hypoventilation (OAH) in order to avoid worsening hypercarbia, but these guidelines have largely been based on anecdotal clinical experience rather than systematically collected evidence.
-
In this study of a large administrative database, the incidence of selected complications in patients diagnosed with sleep apnea (SA) was compared to that in patients undergoing similar surgical procedures who were not diagnosed with SA.
